You're reading the free version. Trader adds the live tape and alerts.
Start tracking
UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Jul 2, 2026
Sale
Calculated transaction value
$747.46K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Jul 2, 2026
Public filing date
Jul 2, 2026
Filing lag
Filed same day
UTHR daily price context
Close on/before transaction
$555.91
Jul 2, 2026
First close after public filing
$547.25
Jul 6, 2026
30-day return after filing
-5.65%
Through Aug 3, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,343 shares @ $556.56
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000091
Filing cohort
Transactions in this filing
Showing 13 of 13
Trades
13
Issuers
1
Estimated value
$6.56M
Buys / sales
0 / 11
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Jul 2, 2026 | $1.29M |
| United Therapeutics Corp UTHR | Sale | Jul 2, 2026 | $105.22K |
| United Therapeutics Corp UTHR | Sale | Jul 2, 2026 | $71.34K |
| United Therapeutics Corp UTHR | Sale | Jul 2, 2026 | $64.87K |
| United Therapeutics Corp UTHR | Sale | Jul 2, 2026 | $353.02K |
| United Therapeutics Corp UTHR | Sale | Jul 2, 2026 | $548.86K |
| United Therapeutics Corp UTHR | Sale | Jul 2, 2026 | $429.62K |
| United Therapeutics Corp UTHR | Sale | Jul 2, 2026 | $1.11M |
| United Therapeutics Corp UTHR | Sale | Jul 2, 2026 | $1.63M |
| United Therapeutics Corp UTHR Current | Sale | Jul 2, 2026 | $747.46K |
| United Therapeutics Corp UTHR | Sale | Jul 2, 2026 | $178.44K |
| United Therapeutics Corp UTHR | Sale | Jul 2, 2026 | $22.33K |
| United Therapeutics Corp UTHR | Exercise | Jul 2, 2026 | $0 |